[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE123036T1 - Methode zur in vitro diagnose von hiv-1 virus infektionen. - Google Patents

Methode zur in vitro diagnose von hiv-1 virus infektionen.

Info

Publication number
ATE123036T1
ATE123036T1 AT92903700T AT92903700T ATE123036T1 AT E123036 T1 ATE123036 T1 AT E123036T1 AT 92903700 T AT92903700 T AT 92903700T AT 92903700 T AT92903700 T AT 92903700T AT E123036 T1 ATE123036 T1 AT E123036T1
Authority
AT
Austria
Prior art keywords
hiv
virus infections
vitro diagnosis
vitro
virus
Prior art date
Application number
AT92903700T
Other languages
English (en)
Inventor
Rossi Anita De
Marcella Pasti
Fabrizio Mammano
Marina Panozzo
Monica Dettin
Bello Carlo Di
Luigi Chieco-Bianchi
Original Assignee
Ist Superiore Sanita
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Superiore Sanita, Consiglio Nazionale Ricerche filed Critical Ist Superiore Sanita
Application granted granted Critical
Publication of ATE123036T1 publication Critical patent/ATE123036T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92903700T 1991-01-30 1992-01-29 Methode zur in vitro diagnose von hiv-1 virus infektionen. ATE123036T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910220A IT1244529B (it) 1991-01-30 1991-01-30 Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1

Publications (1)

Publication Number Publication Date
ATE123036T1 true ATE123036T1 (de) 1995-06-15

Family

ID=11358323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92903700T ATE123036T1 (de) 1991-01-30 1992-01-29 Methode zur in vitro diagnose von hiv-1 virus infektionen.

Country Status (10)

Country Link
US (1) US5527666A (de)
EP (1) EP0569428B1 (de)
JP (1) JPH06509637A (de)
AT (1) ATE123036T1 (de)
AU (1) AU1180392A (de)
DE (1) DE69202698T2 (de)
DK (1) DK0569428T3 (de)
ES (1) ES2073287T3 (de)
IT (1) IT1244529B (de)
WO (1) WO1992013882A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2192937B1 (es) * 2001-05-29 2005-01-01 Universidad Miguel Hernandez De Elche Peptidos activadores de la infectividad del rhabdovirus de la septicemia hemorragica virica (vhsv).
ES2639307T3 (es) 2011-06-30 2017-10-26 Genethon Péptidos con propiedades potenciadoras de infección vírica y su uso

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017688A (en) * 1986-06-12 1991-05-21 Biogen, Inc. Peptides involved in the pathogenesis of HIV infection
WO1990003984A1 (en) * 1988-10-03 1990-04-19 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
CA2058630A1 (en) * 1989-06-05 1990-12-06 Charles F. Scott, Jr. Human monoclonal antibodies to hiv-1 mn gp 120

Also Published As

Publication number Publication date
DE69202698T2 (de) 1995-10-26
DK0569428T3 (da) 1995-07-24
WO1992013882A1 (en) 1992-08-20
US5527666A (en) 1996-06-18
IT1244529B (it) 1994-07-15
JPH06509637A (ja) 1994-10-27
ITMI910220A0 (it) 1991-01-30
ES2073287T3 (es) 1995-08-01
EP0569428B1 (de) 1995-05-24
AU1180392A (en) 1992-09-07
DE69202698D1 (de) 1995-06-29
EP0569428A1 (de) 1993-11-18
ITMI910220A1 (it) 1992-07-30

Similar Documents

Publication Publication Date Title
ATE108068T1 (de) Antikörper-heterokonjugate zur töting von hiv- infizierten zellen.
FI860015A (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
ATE120234T1 (de) Hiv-3-retrovirus und seine verwendung.
ATE98376T1 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
ATE165345T1 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
ATE189394T1 (de) Methode zur behandlung von viralen infektionen
ES2061495T3 (es) Peptidos relacionados con el virus htlv-iii, anticuerpos para los peptidos, vacunas, inmunizacion activa y pasiva contra el virus del sida y prueba diagnostica para la deteccion serologica del virus del sida.
ATE123036T1 (de) Methode zur in vitro diagnose von hiv-1 virus infektionen.
FI885296A0 (fi) Rekombinant hiv-2 polypeptid.
ATE125870T1 (de) Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung.
ATE105938T1 (de) Monoklonale antikörper gegen spezifische antigene regionen des humanen immundefizienzvirus und methoden zur verwendung.
KR900702045A (ko) 천연 hiv gp 160의 제조방법
DE69120925D1 (de) Hämoglobin-oligomer basierte komposition und seine herstellung
DK135588D0 (da) Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler
Storz et al. On enteropathogenic bovine coronavirus
SU1768637A1 (en) Strain of human immunodeficient virus 1-type for preparation of diagnostic preparation
ATE119166T1 (de) An hiv relatierte peptide.
EA199700353A1 (ru) Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции
Williams et al. Susceptibility of rodents to Japanese encephalitis virus.
SE8701294L (sv) Hiv-peptid
Jameson et al. HTLV-III/LAV: The Role of Molecular Biology in Viral Detection and Prevention
IE41024B1 (en) Process for obtaining antigens from schistosomes, agent containing these antigens and its use
MARKOV AN EXPERIMENT IN SANITARY-VIROLOGICAL RESEARCH ON SEWAGE,(IN RUSSIAN)
SU1797350A1 (ru) Способ обнаружения вируса иммунодефицита человека
Montagnier et al. A novel human lymphotropic retrovirus (LAV): New data on its biology and role in AIDS

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee